AbbVie shares rise 1.06% intraday after announcing a $195 million investment in Illinois manufacturing facility.

AbbVie Inc. rose 1.06% in intraday trading, with the company announcing a $195 million investment to expand its North Chicago, Illinois manufacturing plant. This expansion is part of AbbVie's previously announced commitment to invest more than $10 billion of capital in the U.S. over the next decade. The new facility will enhance AbbVie's active pharmaceutical ingredient (API) production capacity and capabilities, furthering the company's long-term commitment to the U.S. and expanding its North Chicago workforce and critical manufacturing capabilities.